Ping Gu Selected Research

Photochemotherapy (Photodynamic Therapy)

7/2021	The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
6/2020	Fluorinated-functionalized hyaluronic acid nanoparticles for enhanced photodynamic therapy of ocular choroidal melanoma by ameliorating hypoxia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ping Gu Research Topics

Disease

21	Neoplasms (Cancer) 03/2024 - 01/2007
10	Inflammation (Inflammations) 01/2023 - 03/2013
9	Parkinson Disease (Parkinson's Disease) 10/2023 - 04/2009
9	Retinal Degeneration 01/2023 - 10/2017
8	Atrial Fibrillation 04/2024 - 01/2023
8	Obesity 02/2023 - 03/2013
8	Type 2 Diabetes Mellitus (MODY) 01/2022 - 09/2011
8	Adenocarcinoma of Lung 01/2022 - 01/2018
6	Hypertension (High Blood Pressure) 01/2023 - 01/2012
5	Hemorrhage 04/2024 - 01/2023
5	Macular Degeneration (Age-Related Maculopathy) 06/2023 - 01/2018
5	Insulin Resistance 01/2022 - 01/2012
4	Melanoma (Melanoma, Malignant) 11/2023 - 09/2011
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2018
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2014
4	Infections 07/2020 - 05/2011
4	Graves Ophthalmopathy 01/2019 - 02/2013
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2024 - 01/2012
3	Neoplasm Metastasis (Metastasis) 02/2024 - 09/2013
3	Carcinogenesis 02/2024 - 01/2021
3	Cognitive Dysfunction 04/2023 - 03/2010
3	Peripheral Nervous System Diseases (PNS Diseases) 04/2023 - 11/2020
3	Body Weight (Weight, Body) 02/2023 - 10/2010
3	Adenocarcinoma 01/2023 - 05/2002
3	Atherosclerosis 01/2023 - 11/2015
3	Uveal melanoma 12/2022 - 10/2010
3	Hypoxia (Hypoxemia) 01/2022 - 11/2012
3	Retinal Diseases 12/2021 - 12/2010
2	Thromboembolism 04/2024 - 01/2023
2	Chronic Renal Insufficiency 03/2024 - 07/2020
2	Diabetes Mellitus 03/2024 - 06/2011
2	Stroke (Strokes) 11/2023 - 01/2020
2	Anemia 11/2023 - 01/2023
2	Stomach Neoplasms (Stomach Cancer) 10/2023 - 06/2008
2	Glaucoma 06/2023 - 10/2017
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 06/2023 - 01/2018
2	Vascular Diseases (Vascular Disease) 01/2023 - 08/2022
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2023 - 02/2012
2	Choroidal Neovascularization 01/2023 - 01/2023
2	Deafness (Deaf Mutism) 01/2022 - 01/2017
2	Blindness (Hysterical Blindness) 01/2022 - 01/2022
2	Sleepiness 01/2022 - 01/2021
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2021 - 01/2018
2	Non-alcoholic Fatty Liver Disease 10/2021 - 10/2021
2	Migraine Disorders (Migraine) 01/2021 - 01/2021
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 05/2008
2	Fibrosis (Cirrhosis) 11/2017 - 01/2016
2	Myopia 01/2017 - 05/2014
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016 - 01/2015
2	Lung Neoplasms (Lung Cancer) 12/2015 - 12/2013

Drug/Important Bio-Agent (IBA)

15	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 06/2011
12	Retinaldehyde (Retinal)IBA 06/2023 - 12/2010
8	AnticoagulantsIBA 04/2024 - 01/2023
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2007
7	LipidsIBA 02/2023 - 11/2013
7	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2018
6	Blood Glucose (Blood Sugar)IBA 05/2021 - 10/2010
5	RivaroxabanIBA 04/2024 - 01/2023
5	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2012
5	AdipokinesIBA 11/2015 - 03/2013
4	Biomarkers (Surrogate Marker)IBA 03/2024 - 09/2011
4	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2012
4	Insulin (Novolin)FDA Link 01/2019 - 06/2011
4	Troleandomycin (TAO)FDA Link 01/2019 - 02/2013
3	Dabigatran FDA Link 04/2024 - 01/2023
3	B7-H1 AntigenIBA 03/2024 - 01/2020
3	Neuroprotective AgentsIBA 10/2023 - 11/2012
3	InterleukinsIBA 04/2023 - 11/2017
3	Messenger RNA (mRNA)IBA 01/2022 - 06/2008
3	CytokinesIBA 01/2022 - 12/2010
3	NAD (NADH)IBA 10/2021 - 12/2013
3	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2021 - 04/2009
3	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 07/2010
3	Interleukin-17 (Interleukin 17)IBA 11/2017 - 01/2016
2	HydrogelsIBA 11/2023 - 01/2023
2	Biocompatible Materials (Biomaterials)IBA 11/2023 - 01/2019
2	C-Reactive ProteinIBA 04/2023 - 01/2014
2	Interleukin-6 (Interleukin 6)IBA 04/2023 - 01/2014
2	SuspensionsIBA 03/2023 - 01/2012
2	Eosine Yellowish-(YS) (Eosin)IBA 02/2023 - 10/2019
2	Hematoxylin (Haematoxylon)IBA 02/2023 - 10/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 11/2012
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 05/2002
2	IronIBA 12/2022 - 12/2021
2	CholesterolIBA 01/2022 - 01/2014
2	EnzymesIBA 01/2022 - 10/2019
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2020 - 01/2007
2	HDL CholesterolIBA 01/2019 - 11/2013
2	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 05/2014
2	Carcinoembryonic AntigenIBA 01/2015 - 01/2007

Therapy/Procedure

20	Therapeutics 02/2024 - 10/2010
8	Drug Therapy (Chemotherapy) 02/2024 - 07/2009
7	Transplantation 01/2023 - 05/2012
6	Radiotherapy 11/2023 - 10/2010
5	Immunotherapy 12/2022 - 09/2011
5	Glycemic Control 01/2022 - 01/2020
2	Intravitreal Injections 01/2023 - 01/2023
2	Injections 01/2023 - 12/2022
2	Photochemotherapy (Photodynamic Therapy) 07/2021 - 06/2020